Viatris (VTRS) Revenue & Revenue Breakdown


OverviewForecastOwnershipFinancialsChartTranscripts

Viatris Revenue Highlights


Latest Revenue (Y)

$15.43B

Latest Revenue (Q)

$3.66B

Main Segment (Y)

Brands

Main Geography (Y)

Developed Markets Segment

Viatris Revenue by Period


Viatris Revenue by Year

DateRevenueChange
2023-12-31$15.43B-5.14%
2022-12-31$16.26B-9.08%
2021-12-31$17.89B49.73%
2020-12-31$11.95B3.87%
2019-12-31$11.50B0.58%
2018-12-31$11.43B-3.98%
2017-12-31$11.91B7.50%
2016-12-31$11.08B17.47%
2015-12-31$9.43B22.15%
2014-12-31$7.72B11.73%
2013-12-31$6.91B1.66%
2012-12-31$6.80B10.87%
2011-12-31$6.13B12.46%
2010-12-31$5.45B7.02%
2009-12-31$5.09B-0.87%
2008-12-31$5.14B218.74%
2007-03-31$1.61B28.21%
2006-03-31$1.26B0.30%
2005-03-31$1.25B-8.82%
2004-03-31$1.37B8.31%
2003-03-31$1.27B14.96%
2002-03-31$1.10B30.40%
2001-03-31$846.70M7.16%
2000-03-31$790.14M9.57%
1999-03-31$721.10M36.42%
1998-03-31$528.60M20.08%
1997-03-31$440.20M12.04%
1996-03-31$392.90M-0.81%
1995-03-31$396.10M57.31%
1994-03-31$251.80M18.77%
1993-03-31$212.00M-

Viatris generated $15.43B in revenue during NA 2023, up -5.14% compared to the previous quarter, and up 134.92% compared to the same period a year ago.

Viatris Revenue by Quarter

DateRevenueChange
2024-03-31$3.66B-4.38%
2023-12-31$3.82B-2.98%
2023-09-30$3.94B0.59%
2023-06-30$3.92B5.08%
2023-03-31$3.73B-3.79%
2022-12-31$3.88B-4.96%
2022-09-30$4.08B-0.94%
2022-06-30$4.12B-1.79%
2022-03-31$4.19B-3.45%
2021-12-31$4.34B-4.30%
2021-09-30$4.54B-0.90%
2021-06-30$4.58B3.33%
2021-03-31$4.43B22.27%
2020-12-31$3.62B21.92%
2020-09-27$2.97B8.82%
2020-06-28$2.73B4.28%
2020-03-29$2.62B-17.94%
2019-12-31$3.19B7.77%
2019-09-30$2.96B3.86%
2019-06-30$2.85B14.27%
2019-03-31$2.50B-18.94%
2018-12-31$3.08B7.56%
2018-09-30$2.86B1.93%
2018-06-30$2.81B4.61%
2018-03-31$2.68B-17.12%
2017-12-31$3.24B8.43%
2017-09-30$2.99B0.84%
2017-06-30$2.96B8.92%
2017-03-31$2.72B-16.78%
2016-12-31$3.27B6.89%
2016-09-30$3.06B19.39%
2016-06-30$2.56B16.86%
2016-03-31$2.19B-12.02%
2015-12-31$2.49B-7.59%
2015-09-30$2.70B13.64%
2015-06-30$2.37B26.71%
2015-03-31$1.87B-10.13%
2014-12-31$2.08B-0.06%
2014-09-30$2.08B13.43%
2014-06-30$1.84B7.09%
2014-03-31$1.72B-5.14%
2013-12-31$1.81B2.33%
2013-09-30$1.77B3.86%
2013-06-30$1.70B4.30%
2013-03-31$1.63B-4.16%
2012-12-31$1.70B-5.93%
2012-09-30$1.81B6.99%
2012-06-30$1.69B6.23%
2012-03-31$1.59B4.00%
2011-12-31$1.53B-2.83%
2011-09-30$1.58B0.12%
2011-06-30$1.57B8.62%
2011-03-31$1.45B1.01%
2010-12-31$1.43B5.86%
2010-09-30$1.36B-0.98%
2010-06-30$1.37B5.89%
2010-03-31$1.29B-4.40%
2009-12-31$1.35B6.94%
2009-09-30$1.26B-0.23%
2009-06-30$1.27B4.72%
2009-03-31$1.21B0.56%
2008-12-31$1.20B-27.38%
2008-09-30$1.66B37.71%
2008-06-30$1.20B11.97%
2008-03-31$1.07B-

Viatris generated $3.66B in revenue during Q1 2024, up -4.38% compared to the previous quarter, and up 94.34% compared to the same period a year ago.

Viatris Revenue Breakdown


Viatris Revenue Breakdown by Product

Annual Revenue by Product

Product/ServiceDec 23Dec 22Dec 21Dec 20
Generics$5.59B$5.02B--
Brands$9.80B$9.89B--
Product-$16.22B$17.81B-
Complex GX and Biosimilars-$1.31B--
Product and Service, Other---$126.10M

Viatris's latest annual revenue breakdown by segment (product or service), as of Dec 23: Brands (63.69%), and Generics (36.31%).

Quarterly Revenue by Product

Product/ServiceMar 24Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21
Brands$2.31B$2.53B----------
Generics$1.34B$1.23B----------
Xalabrands$42.50M$47.90M$48.40M$54.00M$55.80M$58.30M$57.90M-----
Product and Service, Other--$9.10M$10.00M$8.90M$10.80M$11.40M$13.50M----

Viatris's latest quarterly revenue breakdown by segment (product or service), as of Mar 24: Brands (62.48%), Generics (36.37%), and Xalabrands (1.15%).

Viatris Revenue Breakdown by Country

Annual Revenue by Country

CountryDec 23Dec 22Dec 21Dec 20
Greater China Segment$2.16B$2.20B--
Developed Markets Segment$9.25B$9.77B--
Emerging Markets Segment$2.55B$2.62B--
Japan, Australia and New Zealand Segment$1.42B$1.63B--
UNITED STATES-$3.95B$4.18B$3.75B
CHINA-$1.95B$1.98B-
FRANCE---$1.07B
INDIA---$1.16B

Viatris's latest annual revenue breakdown by geography, as of Dec 23: Developed Markets Segment (60.12%), Emerging Markets Segment (16.58%), Greater China Segment (14.04%), and Japan, Australia and New Zealand Segment (9.26%).

Quarterly Revenue by Country

CountryMar 24Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21
Emerging Markets Segment$626.40M-----------
Greater China Segment$543.90M$548.40M$1.60M$2.20M$100.00K$1.90M$1.70M$3.40M$2.70M-$1.10M$1.00M
Japan, Australia and New Zealand Segment$317.80M-----------
Developed Markets Segment$2.17B-----------

Viatris's latest quarterly revenue breakdown by geography, as of Mar 24: Developed Markets Segment (59.27%), Emerging Markets Segment (17.15%), Greater China Segment (14.89%), and Japan, Australia and New Zealand Segment (8.70%).

Viatris Peer Comparison by Revenue


TickerCompanyLast Year RevenueLast Quarter Revenue
TAKTakeda Pharmaceutical Company$4.26T$1.05T
RDYDr. Reddy's Laboratories$279.16B-
TEVATeva Pharmaceutical Industries$15.85B$4.16B
VTRSViatris$15.43B$3.66B
HLNHaleon$11.30B$2.92B
BHCBausch Health Companies$8.76B$2.51B
ZTSZoetis$8.54B$2.36B
ELANElanco Animal Health$4.42B$1.21B
CTLTCatalent$4.38B$1.07B
LNTHLantheus$1.30B$394.09M
EBSEmergent BioSolutions$1.05B$254.70M
HCMHUTCHMED (China)$838.00M$152.56M
TLRYTilray Brands$788.94M$200.04M

VTRS Revenue FAQ


Viatris's yearly revenue for 2023 was $15.43B, representing a decrease of -5.14% compared to 2022. The company's yearly revenue for 2022 was $16.26B, representing a decrease of -9.08% compared to 2021. VTRS's yearly revenue for 2021 was $17.89B, representing an increase of 49.73% compared to 2020.

Viatris's quarterly revenue for Q1 2024 was $3.66B, a -4.38% decrease from the previous quarter (Q4 2023), and a -1.94% decrease year-over-year (Q1 2023). The company's quarterly revenue for Q4 2023 was $3.82B, a -2.98% decrease from the previous quarter (Q3 2023), and a -1.33% decrease year-over-year (Q4 2022). VTRS's quarterly revenue for Q3 2023 was $3.94B, a 0.59% increase from the previous quarter (Q2 2023), and a -3.34% decrease year-over-year (Q3 2022).

Viatris's revenue growth rate for the last 3 years (2021-2023) was -13.75%, and for the last 5 years (2019-2023) was 34.14%.

Viatris's revenue streams in c 23 are Generics, and Brands. Generics generated $5.59B in revenue, accounting 36.31% of the company's total revenue, up 11.42% year-over-year. Brands generated $9.8B in revenue, accounting 63.69% of the company's total revenue, down -0.90% year-over-year.

For the fiscal year ending Dec 23, the largest source of revenue of Viatris was Brands. This segment made a revenue of $9.8B, representing 63.69% of the company's total revenue.